Request Free Demo
"I recently discovered Gynecor TruTest EMB and diagnosed uterine cancer in a very anxious patient. The simple brush device helped me obtain a sample painlessly and without difficulty. The easiest part was the procedure after I calmed the patient down. I received a call about the result from the pathologist quickly. I am impressed with what Gynecor offers!"
Michael J. Heard, M.D.
Reproductive Endocrinology and Infertility Obstetrics and Gynecology

Molecular Tests for Cervicovaginal Pathogens

Gynecor’s TruSwab is a molecular-based test that detects a number of pathogens associated with sexually transmitted diseases and gynecologic infections. TruSwab’s testing platform utilizes both FDA approved assays and LDTs, providing high-diagnostic specificity and sensitivity.


  • Chlamydia1
  • Gonorrhea1
  • HPV Screening or Genotyping1
  • Herpes Simplex Virus 1&22
  • Group B Strep
  • Urogenital Mycoplasma & Ureaplasma Species Panel2

BD Affirm

Gynecor utilizes the FDA approved BD Affirm for detecting three infectious agents that are responsible for up to 95% of infectious vaginitis cases:

  • Gardnerella Vaginalis
  • Candida Species
  • Trichomonas Vaginalis

The BD Affirm test uses DNA probe technology to accurately and quickly identify these pathogens from a single sample. Since up to 25% of vaginal infections are mixed infections, results can help physicians provide appropriate drug therapy for their patients and thereby reduce patient visits.

1 FDA cobas
2 Roche LTD
3 FDA Amplivue